Scientists Scanned Thousands of Anxious Brains and Found One Thing Missing. Do You Have Enough of It?

They put anxious brains in scanners.

Not one study, not one lab, not one country. Twenty-five separate studies, accumulated across more than two decades of research, conducted across multiple institutions, using one of the most precise neuroimaging techniques available to modern science — proton magnetic resonance spectroscopy, a form of MRI that measures the chemistry of living brain tissue without injecting a single drug or drawing a single drop of blood. Seven hundred and twelve people in total: 370 with diagnosed anxiety disorders, 342 without. Social anxiety disorder. Generalized anxiety disorder. Panic disorder. Different diagnoses, different symptom profiles, different clinical presentations.

And then researchers at UC Davis Health gathered all of it together — all 25 datasets, all 712 brains — and looked for a pattern.

They found one.

Across every anxiety disorder they studied, across every dataset, across every institution that had contributed their data to this first-ever meta-analysis of brain chemistry in anxious people, one thing was consistently, measurably, significantly lower in the anxious brain than in the brain without anxiety.

Not a neurotransmitter. Not a hormone. Not a receptor density or a structural brain abnormality or a genetic variant. A nutrient. A single essential nutrient — one that the body cannot make in sufficient quantities on its own, one that must come almost entirely from food, one that approximately 90% of Americans do not consume in adequate amounts — was approximately 8% lower in the brains of people with anxiety disorders.

It is called choline.

You have almost certainly never had a conversation with your doctor about it. You have almost certainly never seen it on a food label you paid attention to. You have almost certainly never been told that your anxious brain might be running short of it.

And if the research published in the journal Molecular Psychiatry — part of the Nature publishing group — represents what the researchers believe it represents, that oversight may be one of the most consequential nutritional blind spots in modern mental health care.

What Was Found in the Scans — and Why It Matters

The UC Davis study was led by Richard Maddock, a psychiatrist and research professor in the Department of Psychiatry and Behavioral Sciences, and his co-author Jason Smucny, an assistant professor in the same department. It was, by any reasonable measure, methodologically rigorous: a systematic review and meta-analysis, the gold standard of evidence synthesis, drawing on 25 published datasets that met strict inclusion criteria.

The imaging technique they analyzed — proton magnetic resonance spectroscopy, or ¹H-MRS — is not a brain photograph. It is something more intimate than that. It measures the specific chemical signatures of metabolites living inside brain tissue, in real time, in living people, without the need for contrast agents or invasive procedures. It can distinguish choline from glutamate from GABA from creatine with specificity that earlier brain imaging could not approach. For 25 years, researchers have been using it to probe the neurochemistry of psychiatric disorders, accumulating individual datasets that, in isolation, produced ambiguous results.

What Maddock and Smucny did was bring those datasets together and ask: when we look at all of them simultaneously, what pattern emerges?

The answer was unambiguous. Choline was about 8% lower in those with anxiety disorders. This reduction was most clearly seen in the prefrontal cortex — a region involved in thinking, emotional regulation, and decision-making.

Eight percent may sound modest. But context matters enormously here. This is not a marginal statistical fluctuation in a single study. This is the first meta-analysis to show a chemical pattern in the brain in anxiety disorders — and it is consistent across social anxiety disorder, generalized anxiety disorder, and panic disorder simultaneously. Three distinct diagnoses, each with its own symptom profile and clinical literature, sharing the same neurochemical signature. Researchers call this kind of finding "transdiagnostic" — it cuts across diagnostic categories rather than being specific to one — and transdiagnostic findings carry particular scientific weight because they suggest something fundamental about the biology underneath the diagnostic labels.

Nona Kocher, a board-certified psychiatrist not involved in the study, described the pattern as potentially indicating stress on metabolic processes. "We know from the clinic that this kind of burden is associated with feeling easily overwhelmed, feeling less resilient under stress and being mentally tired earlier in the day."

That description will be recognizable to anyone who has lived with anxiety: the specific quality of depletion it produces, the way it drains cognitive reserves faster than they refill, the exhausting effort of regulating emotions that, in a less taxed nervous system, would regulate themselves. The finding suggests that this experience may have, at least in part, a measurable biochemical substrate — one that has been visible in brain scanners for years, waiting to be seen.

Why Choline? What This Nutrient Actually Does in Your Brain

Choline is classified as an essential nutrient — meaning the body requires it for fundamental biological functions and cannot produce sufficient amounts on its own. It must come from food. The body synthesizes only a small amount through a liver pathway; the rest — the vast majority of what the brain and body need — must arrive through the diet. And in a modern food environment that has progressively stripped out the richest dietary sources of choline, the arithmetic of adequacy has become increasingly unfavorable.

What does choline actually do in the brain? The answer is several things simultaneously, and understanding them illuminates why a deficit might matter so profoundly in the context of anxiety.

First and most significantly: choline is the direct precursor to acetylcholine, one of the most important neurotransmitters in the central and peripheral nervous systems. Acetylcholine governs memory formation, learning, attention, and — critically — the calm, rest-and-digest parasympathetic nervous system activity that serves as the physiological counterweight to the stress response. Low acetylcholine activity is associated with both anxiety and cognitive decline. The medications most commonly prescribed for early-stage Alzheimer's disease — cholinesterase inhibitors — work specifically by preserving acetylcholine in the brain, preventing its premature breakdown. The fact that the same neurotransmitter implicated in dementia risk also appears to be deficient in anxious brains is not incidental. It points toward choline's centrality in the overall architecture of healthy brain function.

Second: choline is essential for cell membrane integrity throughout the body — and in the brain specifically, where the precise structure of neuronal membranes determines how efficiently electrical signals travel and how effectively synaptic transmission operates. Changes in choline levels reflect changes in membrane dynamics or phospholipid metabolism, according to the study authors. When choline levels drop, the structural substrate of neural communication itself is affected — not catastrophically, not immediately, but in the subtle, cumulative ways that emerge as reduced cognitive resilience, impaired emotional regulation, and a nervous system more easily tipped into the alarm state.

Third: choline plays a significant role in the methylation cycle — the biochemical process that regulates gene expression, DNA repair, and the production of other neurotransmitters including dopamine and serotonin. The methylation cycle is one of the most consequential and most nutritionally sensitive pathways in human biochemistry, and choline is one of its primary methyl donors. A choline-depleted system is a methylation-impaired system — with downstream consequences for mood, cognition, and stress regulation that extend well beyond choline's direct roles.

This is why, as one analysis noted, every other measurable brain metabolite — including glucose, creatine, and glutamate — can be produced by the brain itself. Choline is the only one that must come almost entirely from food. When the food doesn't supply it, there is no meaningful backup system. The brain does not compensate efficiently. It simply operates with less.

The Anxiety-Choline Spiral: Which Came First?

One of the most important questions the UC Davis researchers grappled with — and one that deserves honest examination before anyone draws premature clinical conclusions — is the question of causality. Does low choline cause anxiety? Or does anxiety deplete choline?

The honest answer, at this stage of the evidence, is: the research strongly suggests the second pathway operates, and possibly the first as well — and crucially, both create the same intervention implication.

Norepinephrine is often elevated in anxiety disorders, and the UC Davis researchers suggest that this heightened arousal may increase the brain's demand for choline. Norepinephrine — the primary neurochemical driver of the fight-or-flight response — accelerates the metabolic processes that consume choline. A brain in a chronic state of anxiety-driven arousal is a brain running its choline reserves down faster than a calm brain. Professor Richard Maddock said: "Chronic activation of the 'fight or flight' response increases the brain's need for choline. When stores are depleted, the balance of neurotransmitters is disrupted."

This creates a biologically plausible spiral: anxiety depletes choline, choline depletion impairs the prefrontal regulation that normally modulates anxiety, impaired prefrontal regulation allows anxiety to intensify, intensified anxiety depletes choline further. A loop — not a simple cause or a simple effect, but a mutually reinforcing relationship between a nutritional deficit and a neural state, each amplifying the other.

The spiral model carries a specific and important implication: even if low choline does not originally cause anxiety, restoring adequate choline levels may break the spiral — by supporting the prefrontal cortex's regulatory capacity, by replenishing acetylcholine to support parasympathetic function, by stabilizing the membrane dynamics that efficient neural signaling requires. You cannot eliminate the life circumstances that generate anxiety. But you may be able to restore the neurochemical substrate that determines how much biological resilience your brain brings to those circumstances.

The Deficiency Nobody Is Talking About — Yet Affects Almost Everyone

Here is the number that sits at the center of this entire conversation and that most people reading it will find surprising, possibly alarming:

Roughly 90% of Americans do not meet the recommended daily intake for choline. The target is 425 mg per day for women and 550 mg for men.

Nine in ten. Not a marginal gap in a vulnerable subpopulation. The overwhelming majority of adults, consuming a typical modern diet, are running below the threshold their brains are designed to operate at — for the one brain nutrient that the brain cannot make for itself.

How did this happen? The answer is partly dietary, partly nutritional, and partly a consequence of decades of well-intentioned but ultimately misguided dietary guidance.

Egg yolks, beef liver, and organ meats — the richest food sources of choline — have fallen out of common eating patterns over the past 50 years, following decades of misguided dietary guidance on dietary fat and cholesterol. The advice to reduce egg consumption, driven by concerns about dietary cholesterol that subsequent research has substantially revised, had an unintended casualty: egg yolks are among the single densest sources of choline available in any ordinary diet. An adult eating two whole eggs per day receives approximately 250–300 mg of choline — a significant portion of the daily requirement, from a food that was systematically discouraged for a generation.

Organ meats — liver, kidney, heart — were once dietary staples in virtually every food culture on earth, consumed out of the practical necessity of using whole animals and providing levels of choline, B vitamins, iron, and zinc that no other single food category approaches. They have largely disappeared from the plates of people eating Western diets, replaced by muscle meats that contain a fraction of the choline density.

The ultra-processed food revolution compounded this. Ultra-processed foods — which now supply the majority of calories in the average American diet — are not only low in choline. They are designed around ingredients that contain almost none: refined grains, vegetable oils, sugars, starches. A diet built primarily around ultra-processed products is a diet that can meet caloric needs, macronutrient targets, and even some micronutrient requirements through fortification — while delivering almost no choline whatsoever.

The result is a population that is, by the numbers, almost universally choline-deficient — and that is navigating an anxiety epidemic on brains that are operating without the nutrient those brains most specifically require and cannot produce themselves.

What the Anxious Brain Is Being Asked to Do Without Enough of It

The prefrontal cortex — the region where the choline deficit was most clearly and consistently detected — is not a peripheral brain structure. It is the executive suite of human cognition. It governs decision-making, impulse regulation, working memory, attention, emotional modulation, and the capacity to apply rational perspective to emotionally charged situations.

In anxiety disorders, the prefrontal cortex is precisely the region whose regulatory failure produces the most disabling symptoms. The inability to stop ruminating. The failure of rational reassurance to quiet irrational fear. The exhaustion of trying to talk yourself down from a threat response that does not respond to talking. The sense of emotional overwhelm from inputs that a calm brain would process and move on from. These are, at a neurobiological level, failures of prefrontal regulatory function — the prefrontal cortex unable to perform its inhibitory role over the amygdala and the threat-detection circuitry below it.

When the prefrontal cortex is choline-depleted, its capacity for exactly this regulatory work is reduced. Its ability to produce the acetylcholine that supports calm, focused, parasympathetically balanced attention is compromised. Its membrane dynamics — the structural substrate of how efficiently neurons in the prefrontal cortex communicate — are impaired. And the already-difficult task of a prefrontal cortex managing an anxious brain becomes measurably harder.

This is why the finding is significant beyond its novelty. It suggests that at least part of what we call "anxiety" — the resistance to reassurance, the cognitive rigidity, the emotional dysregulation — may be expressing the biological consequences of a brain trying to do a very hard job with less than the material it requires.

What This Means Right Now — With Appropriate Honesty

The UC Davis researchers are careful — appropriately careful — about the implications of their finding. They noted they "don't know yet if increasing choline in the diet will help reduce anxiety." The finding is correlational, not yet fully causal. It identifies a consistent brain chemistry pattern associated with anxiety disorders; it does not yet prove that restoring choline levels will resolve those disorders. Controlled clinical trials with choline supplementation in anxious populations are the necessary next step — and they are being planned and, in some cases, already conducted.

"It suggests nutritional approaches — like appropriate choline supplementation — may help restore brain chemistry and improve outcomes for patients," said Smucny. That is a scientist's appropriately hedged language for what may nonetheless be a clinically significant insight: that the treatment of anxiety disorders, which has focused for decades on psychotherapy and pharmacology, may have an important nutritional dimension that psychiatry has almost entirely overlooked.

Physicians can use this research to educate patients about the biological basis of anxiety disorders and potential nutritional approaches. This provides an opportunity to discuss evidence-based dietary interventions alongside standard treatments, helping patients understand anxiety as a treatable metabolic condition rather than a character weakness.

That reframing — anxiety as, in part, a metabolic condition with a nutritional dimension — is perhaps the most important clinical implication of the finding. Not because nutrition replaces therapy. Not because a choline-rich diet will resolve severe anxiety disorders on its own. But because a mental health framework that includes the nutritional status of the brain it is trying to treat is a more complete framework than one that ignores it.

Foods rich in choline include beef liver, eggs (particularly the yolk), beef, chicken, fish, soybeans. Salmon occupies a particular place of interest because, as the UC Davis researchers noted, some forms of omega-3 fatty acids, like those found in salmon, may be especially good sources for supplying choline to the brain — with omega-3s enhancing the permeability of the blood-brain barrier in ways that improve choline's delivery to neural tissue. The combination of choline and omega-3 fatty acids in the same food is not incidental. It may be a nutritional synergy that the brain is specifically designed to use.

A word of caution that deserves to sit alongside the encouragement: excessive choline intake — more than 3.5 grams per day — can cause side effects, from nausea to changes in blood pressure. Supplementation should be approached with medical guidance, not enthusiastic self-prescription. The appropriate target is adequacy, not excess — and for most people, adequacy is achievable through dietary change before it requires a supplement protocol.

The Wider Picture: What the Anxious Brain Has Been Trying to Tell Us

Anxiety disorders are, by prevalence, the most common mental illness in the world. They affect approximately 284 million people globally, and in the United States alone, approximately 30% of adults will experience an anxiety disorder at some point in their lives. The treatment options — cognitive behavioral therapy, SSRIs, SNRIs, benzodiazepines — are valuable and for many people, life-changing. They are also, for a significant proportion of people with anxiety disorders, insufficient. Anxiety disorders are highly prevalent and often untreated or unresponsive to treatment — a fact the researchers themselves noted as the framing context for why finding a neurochemical pattern across anxiety diagnoses matters so much.

For decades, the neuroscience of anxiety has focused on serotonin and GABA — the neurotransmitters targeted by the medications most commonly prescribed. That focus has been productive and has helped millions of people. It has also, perhaps, been incomplete. The discovery of a consistent choline pattern across anxiety disorders does not displace the serotonin and GABA models. It adds a dimension they did not include.

And that dimension — nutritional, metabolic, accessible — is one that every person with anxiety can engage with, starting with their next meal, without waiting for a clinical trial, a prescription, or a referral.

Two eggs. A portion of salmon. A handful of edamame. Liver, if your palate allows it. These are not miracle interventions. They are the raw material the brain uses to build acetylcholine, to maintain membrane integrity, to support the prefrontal regulatory capacity that anxiety disorders specifically compromise.

For 25 years, researchers have been scanning anxious brains. For 25 years, the chemical pattern was sitting in the data, waiting to be assembled into something legible. "This is the first meta-analysis to show a chemical pattern in the brain in anxiety disorders," said Jason Smucny — which means, conversely, it is the first time that anxious people have been given something concrete to look at inside their own biology. Not a character flaw. Not a cognitive distortion to be corrected. Not a serotonin imbalance to be chemically adjusted.

A nutrient. One that food can supply. One that the anxious brain specifically, measurably, and consistently has less of.

The scanners have spoken.

Now the question is whether medicine — and every person anxiously Googling their symptoms at 2 AM — is ready to listen.